Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078

Antimicrobial Resistance and Infection Control

Volumn 2, Issue 1, 2013, Pages

  Keessen, Elisabeth C ^b   Hensgens, Marjolein PM ^a   Spigaglia, Patrizia ^c   Barbanti, Fabrizio ^c   Sanders, Ingrid MJG ^a   Kuijper, Ed J ^a   Lipman, Len JA ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; MOXIFLOXACIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; ERM GENE; GENE ACTIVITY; GENETIC ASSOCIATION; HUMAN; INCIDENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PIGLET; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOTYPING;

EID: 84881564406     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-2-14     Document Type: Article

References (33)

1. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault A, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A. A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449. http://dx.doi.org/10.1056/NEJMoa051639, 10.1056/NEJMoa051639, 16322602.
2. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, Johnson S, Gerding DN. An epidemic, toxin gene-variant strain of clostridium difficile. N Engl J Med 2005, 353:2433-2441. http://dx.doi.org/10.1056/NEJMoa051590, 10.1056/NEJMoa051590, 16322603.
3. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, Roberts T, Croyle K, Krystofiak S, Patel-Brown S, Pasculle AW, Paterson DL, Saul M, Harrison LH. A large outbreak of clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone Use •. Infect Control Hosp Epidemiol 2005, 26:273-280. http://dx.doi.org/10.1086/502539, 10.1086/502539, 15796280.
4. Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill 2009, 14:19402.
5. Bauer, M. P., D. W. Notermans, B. H. van Benthem, J. S. Brazier, M. H. Wilcox, M. Rupnik, D. L. Monnet, J. T. van Dissel, E. J. Kuijper, and ECDIS Study Group Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73. 10.1016/S0140-6736(10)61266-4, 21084111, Bauer, M. P., D. W. Notermans, B. H. van Benthem, J. S. Brazier, M. H. Wilcox, M. Rupnik, D. L. Monnet, J. T. van Dissel, E. J. Kuijper, and ECDIS Study Group.
6. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008, 47:1162-1170. 10.1086/592257, 18808358.
7. Debast SB, van Leengoed LA, Goorhuis A, Harmanus C, Kuijper EJ, Bergwerff AA. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol 2009, 11:505-511. 10.1111/j.1462-2920.2008.01790.x, 19196280.
8. Keel K, Brazier JS, Post KW, Weese S, Songer JG. Prevalence of PCR Ribotypes among Clostridium difficile Isolates from Pigs, Calves, and Other Species{down triangle, open}. J Clin Microbiol 2007, 45:1963-1964. 10.1128/JCM.00224-07, 1933037, 17428945.
9. Keessen EC, Hopman NE, van Leengoed LA, van Asten AJ, Hermanus C, Kuijper EJ, Lipman LJ. Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets. J Clin Microbiol 2011, 49:1816-1821. 10.1128/JCM.00242-11, 3122649, 21411571.
10. Songer JG, Anderson MA. Clostridium difficile: an important pathogen of food animals. Anaerobe 2006, 12:1-4. 10.1016/j.anaerobe.2005.09.001, 16701605.
11. Songer JG. The emergence of Clostridium difficile as a pathogen of food animals. Anim Health Res Rev 2004, 5:321-326. 10.1079/AHR200492, 15984348.
12. Anderson MA, Songer JG. Evaluation of two enzyme immunoassays for detection of Clostridium difficile toxins A and B in swine. Vet Microbiol 2008, 128:204-206. 10.1016/j.vetmic.2007.09.022, 18006252.
13. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl 1):S12-8. 10.1086/521863, 18177217.
14. Anonymous 2011, Eucast2, http://217.70.33.99/Eucast2/SearchController/search.jsp?action=performSearch&BeginIndex=0&Micdif=mic&NumberIndex=50&Antib=-1&Specium=222.
15. Hecht DW, Citron DM, Dzink-Fox J, Gregory WW, Jacobus NV, Jenkins SG, Rosenblatt JE, Schuetz AN, Wexler H. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard - eighth edition. 2012, 32:M11-A8.
16. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002, 40:3470-3475. 10.1128/JCM.40.9.3470-3475.2002, 130716, 12202595.
17. Spigaglia P, Barbanti F, Mastrantonio P. Detection of a genetic linkage between genes coding for resistance to tetracycline and erythromycin in Clostridium difficile. Microb Drug Resist 2007, 13:90-95. 10.1089/mdr.2007.723, 17650959.
18. Spigaglia P, Mastrantonio P. Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 2004, 53:1129-1136. 10.1099/jmm.0.45682-0, 15496392.
19. Spigaglia P, Barbanti F, Louie T, Barbut F, Mastrantonio P. Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro. Antimicrob Agents Chemother 2009, 53:2463-2468. 10.1128/AAC.01252-08, 2687229, 19364867.
20. Spigaglia, P., F. Barbanti, P. Mastrantonio, and European Study Group on Clostridium difficile (ESGCD) Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother 2011, 66:2227-2234. 10.1093/jac/dkr292, 21771851, Spigaglia, P., F. Barbanti, P. Mastrantonio, and European Study Group on Clostridium difficile (ESGCD).
21. Solomon K, Fanning S, McDermott S, Murray S, Scott L, Martin A, Skally M, Burns K, Kuijper E, Fitzpatrick F, Fenelon L, Kyne L. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. J Antimicrob Chemother 2011, 66:1976-1982. 10.1093/jac/dkr275, 21712239.
22. Grave K, Torren-Edo J, Mackay D. Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother 2010, 65:2037-2040. 10.1093/jac/dkq247, 20587611.
23. Coenen S, Adriaenssens N, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Project Group ESAC. European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009). J Antimicrob Chemother 2011, 66(Suppl 6):vi57-70. 10.1093/jac/dkr458, 22096067.
24. Anonymous Antibiotic use - Wageningen UR - LEI 2011, http://www.maran.wur.nl/.
25. Norman KN, Harvey RB, Scott HM, Hume ME, Andrews K, Brawley AD. Varied prevalence of Clostridium difficile in an integrated swine operation. Anaerobe 2009, 15:256-260. 10.1016/j.anaerobe.2009.09.006, 19778624.
26. Bakker D, Corver J, Harmanus C, Goorhuis A, Keessen EC, Fawley WN, Wilcox MH, Kuijper EJ. Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol 2010, 48:3744-3749. 10.1128/JCM.01171-10, 2953124, 20686080.
27. Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, Johnson S, Gerding DN, McDonald LC, Limbago BM. Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 2008, 14:1039-1045. 10.3201/eid1407.071641, 2630049, 18598622.
28. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, Trinh HT, Witney AA, Hinds J, Wren BW. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 2006, 188:7297-7305. 10.1128/JB.00664-06, 1636221, 17015669.
29. Hunter PA, Dawson S, French GL, Goossens H, Hawkey PM, Kuijper EJ, Nathwani D, Taylor DJ, Teale CJ, Warren RE, Wilcox MH, Woodford N, Wulf MW, Piddock LJ. Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother 2010, 65(Suppl 1):i3-17. 10.1093/jac/dkp433, 20045808.
30. Spigaglia P, Barbanti F, Mastrantonio P, Brazier JS, Barbut F, Delmee M, Kuijper E, Poxton IR, European Study Group on Clostridium difficile (ESGCD) Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J Med Microbiol 2008, 57:784-789. 10.1099/jmm.0.47738-0, 18480338, European Study Group on Clostridium difficile (ESGCD).
31. Drudy D, Kyne L, O'Mahony R, Fanning S. gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis 2007, 13:504-505. 10.3201/eid1303.060771, 2725882, 17552115.
32. Spigaglia P, Barbanti F, Mastrantonio P. New variants of the tet(M) gene in Clostridium difficile clinical isolates harbouring Tn916-like elements. J Antimicrob Chemother 2006, 57:1205-1209. 10.1093/jac/dkl105, 16565156.
33. Post KW, Songer JG. Antimicrobial susceptibility of Clostridium difficile isolated from neonatal pigs with enteritis. Anaerobe 2004, 10:47-50. 10.1016/j.anaerobe.2004.01.003, 16701500.